CN1049686C
(zh)
*
|
1987-11-18 |
2000-02-23 |
希龙股份有限公司 |
非a和非b肝炎病毒的诊断及疫苗
|
US5698390A
(en)
|
1987-11-18 |
1997-12-16 |
Chiron Corporation |
Hepatitis C immunoassays
|
US6171782B1
(en)
|
1987-11-18 |
2001-01-09 |
Chiron Corporation |
Antibody compositions to HCV and uses thereof
|
US5714596A
(en)
*
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
US5712088A
(en)
*
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
US5350671A
(en)
*
|
1987-11-18 |
1994-09-27 |
Chiron Corporation |
HCV immunoassays employing C domain antigens
|
US5683864A
(en)
*
|
1987-11-18 |
1997-11-04 |
Chiron Corporation |
Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
|
US6861212B1
(en)
|
1987-11-18 |
2005-03-01 |
Chiron Corporation |
NANBV diagnostics and vaccines
|
JP2696116B2
(ja)
*
|
1988-09-30 |
1998-01-14 |
財団法人阪大微生物病研究会 |
非a非b肝炎患者の血清と抗原抗体反応するペプチド、及び該ペプチドをコードするdna
|
US5191064A
(en)
*
|
1988-09-30 |
1993-03-02 |
The Research Foundation For Microbial Diseases (Osaka University) |
Non-a, non-b hepatitis virus antigen peptide
|
JPH02167081A
(ja)
*
|
1988-12-21 |
1990-06-27 |
Tetsuo Nakamura |
非A非B型肝炎ウイルスゲノムRNA、cDNAおよびウイルス抗原蛋白質
|
JP2656995B2
(ja)
*
|
1989-03-17 |
1997-09-24 |
カイロン コーポレイション |
Nanbvの診断用薬
|
US6027729A
(en)
*
|
1989-04-20 |
2000-02-22 |
Chiron Corporation |
NANBV Diagnostics and vaccines
|
ES2166749T3
(es)
*
|
1989-05-18 |
2002-05-01 |
Chiron Corp |
Diagnosticos de nanbv: polinucleotidos utiles para discriminar virus de la hepatitis c.
|
JPH0330676A
(ja)
*
|
1989-06-28 |
1991-02-08 |
Sanwa Kagaku Kenkyusho Co Ltd |
非a非b型肝炎ウイルスのdna、そのクローン及びこれらの調製法
|
EP0416725A3
(en)
*
|
1989-07-14 |
1991-03-20 |
Chugai Seiyaku Kabushiki Kaisha |
Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
|
DE69031791T2
(de)
*
|
1989-08-25 |
1998-04-02 |
Chiron Corp |
Verfahren zur HCV-Züchtung in Zell-Linien aus B- oder T-Lymphozyten
|
JP3156200B2
(ja)
*
|
1989-09-15 |
2001-04-16 |
国立予防衛生研究所長 |
新規のhcv分離株
|
US5372928A
(en)
*
|
1989-09-15 |
1994-12-13 |
Chiron Corporation |
Hepatitis C virus isolates
|
FR2654113A1
(fr)
*
|
1989-11-09 |
1991-05-10 |
Pasteur Institut |
Procede de diagnostic de virus appartenant a la famille des flaviviridae.
|
BR9006422A
(pt)
*
|
1989-12-18 |
1991-09-24 |
Wellcome Found |
Processo para preparar um polipeptidio viral pt-nanbh e processo para detectar o mesmo
|
US7166287B1
(en)
|
1989-12-18 |
2007-01-23 |
Glaxo Wellcome Inc. |
Viral agent
|
CA2032907C
(en)
*
|
1989-12-22 |
2002-05-14 |
Richard R. Lesniewski |
Hepatitis c assay
|
US5308750A
(en)
*
|
1989-12-22 |
1994-05-03 |
Abbott Laboratories |
Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
|
EP0435229A1
(en)
*
|
1989-12-27 |
1991-07-03 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
|
EP0441644B1
(en)
*
|
1990-02-09 |
1996-09-11 |
Immuno Japan Inc. |
Non-A, non-B hepatitis related nucleic acids, antigens, antibodies and their detection reagents
|
US5582968A
(en)
*
|
1990-02-16 |
1996-12-10 |
United Biomedical, Inc. |
Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
|
KR940000755B1
(ko)
*
|
1990-02-16 |
1994-01-29 |
유나이티드 바이오메디칼 인코오포레이티드 |
Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
|
US5639594A
(en)
*
|
1990-02-16 |
1997-06-17 |
United Biomedical, Inc. |
Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
|
US5747239A
(en)
*
|
1990-02-16 |
1998-05-05 |
United Biomedical, Inc. |
Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
|
US5106726A
(en)
*
|
1990-02-16 |
1992-04-21 |
United Biomedical, Inc. |
Synthetic peptides specific for the detection of antibodies to HCV
|
EP0445801A3
(en)
*
|
1990-03-08 |
1992-07-01 |
Kuraray Co., Ltd. |
Peptide and its use
|
EP0447984A1
(en)
*
|
1990-03-20 |
1991-09-25 |
Abbott Laboratories |
Hyperimmune globulin against hepatitis C virus and method for making same
|
WO1991014779A1
(en)
*
|
1990-03-28 |
1991-10-03 |
Mitsui Toatsu Chemicals, Incorporated |
Diagnostic for hepatitis virus
|
JPH0436185A
(ja)
*
|
1990-03-28 |
1992-02-06 |
Kyowa Hakko Kogyo Co Ltd |
融合抗原ポリペプチド
|
ATE270326T1
(de)
*
|
1990-04-04 |
2004-07-15 |
Chiron Corp |
Protease von hepatitis-c-virus
|
JP2733138B2
(ja)
*
|
1990-04-04 |
1998-03-30 |
カイロン コーポレイション |
抗hcv抗体の免疫アッセイに使用するc型肝炎ウイルス(hcv)抗原の組合せ
|
US6194140B1
(en)
|
1990-04-04 |
2001-02-27 |
Chiron Corporation |
HCV NS3 protein fragments having helicase activity and improved solubility
|
US6312889B1
(en)
|
1990-04-04 |
2001-11-06 |
Chiron Corporation |
Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
|
EP1018558A3
(en)
*
|
1990-04-06 |
2002-06-05 |
Genelabs Technologies, Inc. |
Hepatitis C Virus Epitopes
|
JP3050395B2
(ja)
*
|
1990-06-12 |
2000-06-12 |
国立感染症研究所長 |
C型肝炎ウイルス抗原ポリペプチド、その産生方法および抗体の検出方法
|
EP0461863A1
(en)
*
|
1990-06-12 |
1991-12-18 |
Immuno Japan Inc. |
Oligonucleotide primers, and their application for high-fidelity detection of non-A, non-B hepatitis virus
|
US5747339A
(en)
|
1990-06-25 |
1998-05-05 |
Research Foundation For Microbial Diseases Of Osaka |
Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
|
FI913068A
(fi)
*
|
1990-06-25 |
1991-12-26 |
Univ Osaka Res Found |
Non-a-, non-b-hepatitisviruspartiklar.
|
EP0464287A1
(en)
*
|
1990-06-25 |
1992-01-08 |
The Research Foundation for Microbial Diseases of Osaka University |
Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
|
EP0551275B1
(en)
*
|
1990-06-30 |
1994-12-21 |
Akzo Nobel N.V. |
Non-a non-b sequences
|
KR0181517B1
(ko)
*
|
1990-07-09 |
1999-04-01 |
나까하라 노부유끼 |
비-에이 비-비형 간염-특이 항원 및 간염 진단에서 그의 용도
|
ATE150086T1
(de)
*
|
1990-07-11 |
1997-03-15 |
Shionogi & Co |
Cdns-sequenz und detektion des hepatitis c-virus
|
WO1992001714A1
(en)
*
|
1990-07-24 |
1992-02-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Non-a non-b hepatitis virus antigen
|
CA2047792C
(en)
*
|
1990-07-26 |
2002-07-02 |
Chang Y. Wang |
Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
|
KR920004577A
(ko)
*
|
1990-08-24 |
1992-03-27 |
원본미기재 |
단백질 합성의 cks 방법
|
US6172189B1
(en)
*
|
1990-08-24 |
2001-01-09 |
Abbott Laboratories |
Hepatitis C assay utilizing recombinant antigens
|
CA2049679C
(en)
*
|
1990-08-24 |
2005-06-21 |
Sushil G. Devare |
Hepatitis c assay utilizing recombinant antigens
|
US7863008B2
(en)
|
1990-08-25 |
2011-01-04 |
Bioprocess Pty Ltd. |
Method for detecting NANBV associated seroconversion
|
DE69133552C5
(de)
*
|
1990-08-25 |
2008-01-10 |
F. Hoffmann-La Roche Ltd. |
Nicht-A, nicht-B Hepatitis Virus Antigen, und diagnostische Verfahren.
|
WO1992007001A1
(en)
*
|
1990-10-12 |
1992-04-30 |
Abbott Laboratories |
Hepatitis c virus antibody
|
JP3549201B2
(ja)
*
|
1990-10-24 |
2004-08-04 |
中外製薬株式会社 |
非a非b型肝炎特異的遺伝子の検出方法及び検出用試薬組成物
|
DE4120281C2
(de)
*
|
1991-06-19 |
1999-11-25 |
Dade Behring Marburg Gmbh |
Immunchemisches Verfahren zum gleichzeitigen Nachweis von mehreren verschiedenen Antikörperspezifitäten, Peptidmischungen und Test dazu
|
DE4034982C2
(de)
*
|
1990-11-03 |
1999-12-23 |
Dade Behring Marburg Gmbh |
Synthetische Polypeptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren
|
DE4112743C2
(de)
*
|
1991-04-19 |
2000-01-13 |
Dade Behring Marburg Gmbh |
Synthetische Core-Peptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren
|
ES2255068T5
(es)
*
|
1990-11-03 |
2010-08-03 |
Siemens Healthcare Diagnostics Products Gmbh |
Peptidos especificos para vhc, sus agentes y su utilizacion.
|
DE4121431A1
(de)
*
|
1991-06-28 |
1993-01-07 |
Behringwerke Ag |
Synthetische core-peptide zur bestimmung von hcv-antikoerpern und hcv-antigenen, mittel dazu und ihre verwendung in diesen nachweis-verfahren
|
US5753430A
(en)
*
|
1990-11-07 |
1998-05-19 |
Abbott Laboratories |
Monoclonal antibodies to hepatitis C virus and method for using same
|
DE69131046T2
(de)
*
|
1990-11-07 |
1999-10-21 |
Abbott Laboratories, Abbott Park |
Monoklonale antikörper gegen den hepatitis c-virus und verfahren diese zu benutzen
|
EP0485209A1
(en)
*
|
1990-11-08 |
1992-05-13 |
Immuno Japan Inc. |
Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
|
SK285624B6
(sk)
*
|
1990-11-08 |
2007-05-03 |
Chiron Corporation |
Hepatitis C vírusový (HCV) skrátený asialoglykoproteín, kompozícia s jeho obsahom a jeho použitie
|
US6274148B1
(en)
|
1990-11-08 |
2001-08-14 |
Chiron Corporation |
Hepatitis C virus asialoglycoproteins
|
EP0516859A1
(en)
*
|
1990-11-29 |
1992-12-09 |
Toray Industries, Inc. |
Non-a non-b hepatitis virus antigen protein
|
EP0488812B1
(en)
*
|
1990-11-30 |
1999-06-09 |
Immuno Japan Inc. |
Non-A, non-B hepatitis related nucleic acids, antigens, antibodies and their detection reagents
|
US5910404A
(en)
*
|
1990-12-14 |
1999-06-08 |
Innogenetics N.V. |
Synthetic antigens for the detection of antibodies to hepatitis C virus
|
DK0489968T3
(da)
*
|
1990-12-14 |
1997-03-24 |
Innogenetics Nv |
Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
|
US6007982A
(en)
*
|
1990-12-14 |
1999-12-28 |
Innogenetics N.V. |
Synthetic antigens for the detection of antibodies to hepatitis C virus
|
CA2101056A1
(en)
*
|
1991-01-25 |
1992-07-26 |
Adrienne L. Gilbert |
Use of superoxide dismutase in specimen diluent
|
ATE167522T1
(de)
*
|
1991-01-31 |
1998-07-15 |
Abbott Lab |
Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen
|
CA2082924A1
(en)
*
|
1991-03-26 |
1992-09-27 |
David C. Leahy |
Assay for non-a non-b hepatitis
|
US5574132A
(en)
*
|
1991-04-05 |
1996-11-12 |
Biochem Immunosystems Inc. |
Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
|
EP0516270A3
(en)
*
|
1991-04-10 |
1993-06-23 |
Immuno Japan Inc. |
Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides
|
WO1992018532A1
(en)
*
|
1991-04-17 |
1992-10-29 |
Eisai Co., Ltd. |
Rna, dna and virus antigen protein of non-a non-b hepatitis virus
|
EP0510952A1
(en)
*
|
1991-04-26 |
1992-10-28 |
Immuno Japan Inc. |
Oligonucleotide primers and their application for high-fidelity detection of non-a, non-b hepatitis virus
|
CZ288720B6
(cs)
*
|
1991-05-08 |
2001-08-15 |
Chiron Corporation |
Nukleová kyselina, kompozice s jejím obsahem, způsob tvorby hybridizačního produktu a způsob detekce genotypů HCV
|
ES2040615B1
(es)
*
|
1991-05-27 |
1994-05-16 |
Nebrda Fernando Javi Bartolome |
Procedimiento para el aislamiento y clonaje de cdnas derivados del virus c de la hepatitis.
|
FR2677372B1
(fr)
|
1991-06-06 |
1994-11-10 |
Pasteur Institut |
Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
|
WO1992022655A1
(en)
|
1991-06-10 |
1992-12-23 |
Lucky Limited |
Hepatitis c diagnostics and vaccines
|
CA2070952A1
(en)
*
|
1991-06-11 |
1992-12-12 |
Makoto Seki |
Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
|
JP3516681B2
(ja)
*
|
1991-06-24 |
2004-04-05 |
カイロン コーポレイション |
C型肝炎ウイルス(hcv)ポリペプチド
|
DE4209215A1
(de)
|
1991-07-04 |
1993-01-07 |
Boehringer Mannheim Gmbh |
Hcv peptidantigene und verfahren zur bestimmung von hcv
|
CA2112667C
(en)
*
|
1991-08-21 |
2004-02-17 |
Smriti U. Mehta |
Monoclonal antibodies to putative hcv ns5 proteins and methods for using same
|
WO1993004089A1
(en)
*
|
1991-08-21 |
1993-03-04 |
Abbott Laboratories |
Hepatitis c assay utilizing recombinant antigens from ns5 region
|
WO1993004088A1
(en)
*
|
1991-08-21 |
1993-03-04 |
Abbott Laboratories |
Hepatitis c assay utilizing recombinant antigens to ns1
|
PT787807E
(pt)
*
|
1991-08-27 |
2003-08-29 |
Hoffmann La Roche |
Iniciadores e sondas para a deteccao da hepatite c
|
DK0608261T3
(da)
|
1991-09-13 |
2003-03-17 |
Chiron Corp |
Sammensætninger med immunreaktivt hepatitis C virus polypeptid
|
ZA927837B
(en)
*
|
1991-10-15 |
1994-03-11 |
Akzo Nv |
Monoclonal antibodiesto hepatitis C virus
|
EP0573624A4
(en)
*
|
1991-11-07 |
1997-09-17 |
Baxter Diagnostics Inc |
Epitope mapping ot the c33c region of hcv
|
JPH05130874A
(ja)
*
|
1991-11-07 |
1993-05-28 |
Sanwa Kagaku Kenkyusho Co Ltd |
ヒトC型肝炎ウイルスのcDNA、そのクローン及びこれらの利用法
|
DE610436T1
(de)
|
1991-11-21 |
1995-08-03 |
Common Services Agency |
Detektion des Hepatis-C Virus.
|
AU666176B2
(en)
*
|
1992-01-31 |
1996-02-01 |
Abbott Laboratories |
Mammalian expression systems for HCV proteins
|
US6709828B1
(en)
|
1992-03-06 |
2004-03-23 |
N.V. Innogenetics S.A. |
Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
|
US6667387B1
(en)
|
1996-09-30 |
2003-12-23 |
N.V. Innogenetics S.A. |
HCV core peptides
|
US6620414B2
(en)
|
1992-03-27 |
2003-09-16 |
Smithkline Beecham Biologicals (S.A.) |
Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
|
MA22842A1
(fr)
*
|
1992-03-27 |
1993-10-01 |
Smithkline Beecham Biolog |
Procede de preparation de compositions de vaccin.
|
US5866139A
(en)
*
|
1992-06-04 |
1999-02-02 |
Institut Pasteur |
Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
|
US5980899A
(en)
*
|
1992-06-10 |
1999-11-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells
|
UA39944C2
(uk)
|
1992-07-07 |
2001-07-16 |
Чірон Корпорейшн |
Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
|
US5859230A
(en)
*
|
1992-07-30 |
1999-01-12 |
Genelabs Technologies, Inc. |
Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof
|
DE4240980A1
(de)
*
|
1992-08-07 |
1994-02-10 |
Boehringer Mannheim Gmbh |
HCV Peptidantigene und Verfahren zur Bestimmung von HCV
|
US6433159B1
(en)
|
1992-09-10 |
2002-08-13 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus associated diseases
|
ATE202383T1
(de)
|
1992-09-10 |
2001-07-15 |
Isis Pharmaceuticals Inc |
Zusammensetzungen und verfahren für die behandlung von mit hepatitis c viren assoziierten krankheiten
|
US6174868B1
(en)
|
1992-09-10 |
2001-01-16 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of hepatitis C virus-associated diseases
|
US6391542B1
(en)
|
1992-09-10 |
2002-05-21 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus-associated diseases
|
US6995146B2
(en)
|
1992-09-10 |
2006-02-07 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of hepatitis C virus-associated diseases
|
US5922857A
(en)
*
|
1992-09-28 |
1999-07-13 |
Chiron Corporation |
Methods and compositions for controlling translation of HCV proteins
|
CN1059928C
(zh)
*
|
1992-09-29 |
2000-12-27 |
天津普生生物科技有限公司 |
利用大肠杆菌制备可用来检验c型肝炎之抗原蛋白的方法
|
JP2778886B2
(ja)
*
|
1992-10-16 |
1998-07-23 |
エバーニュー バイオテック インコーポレイティド |
C型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット
|
JPH06153959A
(ja)
*
|
1992-10-16 |
1994-06-03 |
Evernew Biotec Inc |
C型肝炎ウィルスの非構造タンパク質及びそれを用いての診断方法及びキット
|
US6153378A
(en)
*
|
1992-10-16 |
2000-11-28 |
Bionova Corporation |
Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
|
EP0593291A3
(en)
*
|
1992-10-16 |
1995-03-15 |
Evernew Biotech Inc |
Non-structural protein of the hepatitis C virus, as well as diagnostic procedure and test kit.
|
WO1994013699A1
(en)
*
|
1992-12-07 |
1994-06-23 |
Akzo Nobel N.V. |
Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv
|
CA2151126A1
(en)
*
|
1992-12-07 |
1994-06-23 |
Winand Johannes Antonius Habets |
Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv
|
WO1994024565A1
(en)
*
|
1993-04-22 |
1994-10-27 |
Genelabs Technologies, Inc. |
Hepatitis c virus immunodiagnostic antigens and antibodies
|
SG50563A1
(en)
*
|
1993-04-27 |
1998-07-20 |
Innogenetics Nv |
New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
|
JP3751315B2
(ja)
|
1993-05-05 |
2006-03-01 |
コモン サーヴィシス エージェンシー |
C型肝炎ウイルス4、5及び6型
|
WO1994027153A1
(en)
*
|
1993-05-10 |
1994-11-24 |
Chiron Corporation |
Methods of typing hepatitis c virus and reagents for use therein
|
EP1421951A3
(en)
|
1993-05-12 |
2005-10-05 |
Chiron Corporation |
Conserved motif of hepatitis C virus E2/NS1 region
|
AU8003894A
(en)
*
|
1993-10-29 |
1995-05-22 |
Srl Inc. |
Antigen peptide compound and immunoassay method
|
US5610009A
(en)
*
|
1994-01-28 |
1997-03-11 |
Abbott Laboratories |
Mammalian expression systems for hepatitis C virus envelope genes
|
US5981172A
(en)
*
|
1994-02-14 |
1999-11-09 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
|
US6558898B1
(en)
|
1994-02-14 |
2003-05-06 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US5843450A
(en)
*
|
1994-02-14 |
1998-12-01 |
Abbott Laboratories |
Hepatitis GB Virus synthetic peptides and uses thereof
|
US6156495A
(en)
*
|
1994-02-14 |
2000-12-05 |
Abbott Laboratories |
Hepatitis GB virus recombinant proteins and uses thereof
|
US6451578B1
(en)
|
1994-02-14 |
2002-09-17 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US6051374A
(en)
*
|
1994-02-14 |
2000-04-18 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US6720166B2
(en)
|
1994-02-14 |
2004-04-13 |
Abbott Laboratories |
Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
|
US5824507A
(en)
*
|
1994-05-20 |
1998-10-20 |
Genelabs Technologies, Inc. |
Hepatitis G virus and molecular cloning thereof
|
US5874563A
(en)
*
|
1994-05-20 |
1999-02-23 |
Genelabs Technologies, Inc. |
Hepatitis G virus and molecular cloning thereof
|
JP3217600B2
(ja)
|
1994-07-12 |
2001-10-09 |
株式会社先端生命科学研究所 |
非a非b型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
|
PT773957E
(pt)
*
|
1994-07-29 |
2005-11-30 |
Chiron Corp |
Polipeptidos truncados e1 e e2 de hepatite c inovadores, e metodos de obtencao dos mesmos
|
ES2316920T3
(es)
|
1994-07-29 |
2009-04-16 |
Novartis Vaccines And Diagnostics, Inc. |
Popipeptido truncado e2 de hepatitis c y procedimientos para obtener el mismo.
|
DE4428705A1
(de)
|
1994-08-12 |
1996-02-15 |
Boehringer Mannheim Gmbh |
Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
|
US5955318A
(en)
*
|
1995-08-14 |
1999-09-21 |
Abbott Laboratories |
Reagents and methods useful for controlling the translation of hepatitis GBV proteins
|
US5807670A
(en)
*
|
1995-08-14 |
1998-09-15 |
Abbott Laboratories |
Detection of hepatitis GB virus genotypes
|
US5709997A
(en)
*
|
1995-08-14 |
1998-01-20 |
Abbott Laboratories |
Nucleic acid detection of hepatitis GB virus
|
US6127116A
(en)
|
1995-08-29 |
2000-10-03 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
GB9517926D0
(en)
|
1995-09-01 |
1995-11-01 |
Biocine Spa |
Binding protein
|
US5851758A
(en)
*
|
1995-10-25 |
1998-12-22 |
Childrens Research Institute |
Cytopathic replication of hepatitis C virus in a new cell line
|
US5837442A
(en)
|
1995-11-29 |
1998-11-17 |
Roche Molecular Systems, Inc. |
Oligonucleotide primers for amplifying HCV nucleic acid
|
US5851759A
(en)
*
|
1996-04-19 |
1998-12-22 |
Chiron Corporation |
Heteroduplex tracking assay (HTA) for genotyping HCV
|
JP3715027B2
(ja)
|
1996-05-07 |
2005-11-09 |
シスメックス株式会社 |
C型肝炎ウイルス感染症診断薬
|
CU22642A1
(es)
*
|
1996-12-12 |
2000-12-22 |
Ct Ingenieria Genetica Biotech |
Secuencia de adnc derivadas del genoma del virus de la hepatitis c y su uso
|
US7049428B1
(en)
|
1998-03-04 |
2006-05-23 |
Washington University |
HCV variants
|
US7338759B1
(en)
|
1997-03-04 |
2008-03-04 |
Washington University |
HCV variants
|
JP4458556B2
(ja)
|
1997-05-06 |
2010-04-28 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
C型肝炎のe2短縮型ポリペプチドの細胞内生成
|
US6010848A
(en)
*
|
1997-07-02 |
2000-01-04 |
Smithkline Beecham Corporation |
Screening methods using an atpase protein from hepatitis C virus
|
US6153392A
(en)
*
|
1997-07-30 |
2000-11-28 |
Bionova Corporation |
Devices and methods comprising an HBcAg from hepatitis B virus
|
CA2304796C
(en)
|
1997-10-06 |
2013-12-03 |
Chiron S.P.A. |
Hepatitis c receptor protein cd81
|
CA2308606A1
(en)
|
1997-11-06 |
1999-05-20 |
Chiron S.P.A. |
Neisserial antigens
|
DE69838513T2
(de)
|
1997-12-11 |
2008-07-03 |
Smithkline Beecham Corp. |
Verkürztes hepatitis-c-virus protein nsb5 und methoden, um antivirale substanzen zu identifizieren
|
PT1047784E
(pt)
|
1998-01-14 |
2009-12-21 |
Novartis Vaccines & Diagnostic |
Antigénios de neisseria meningitidis
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
EP2261346A3
(en)
|
1998-05-01 |
2012-01-04 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria meningitidis antigens and compositions
|
CA2366688A1
(en)
|
1999-02-26 |
2000-08-31 |
Chiron Corporation |
Use of bioadhesives and adjuvants for the mucosal delivery of antigens
|
JP2002537102A
(ja)
|
1999-02-26 |
2002-11-05 |
カイロン コーポレイション |
吸着された高分子および微粒子を有するミクロエマルジョン
|
EP2278007B1
(en)
|
1999-04-30 |
2014-04-16 |
Novartis Vaccines and Diagnostics S.r.l. |
Conserved neisserial antigens
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
CA2377525A1
(en)
*
|
1999-07-19 |
2001-03-29 |
Epimmune, Inc. |
Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
|
CA2954411A1
(en)
|
1999-10-29 |
2001-05-03 |
Novartis Vaccines And Diagnostics S.R.L. |
Neisserial antigenic peptides
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
ES2319727T3
(es)
*
|
1999-12-01 |
2009-05-12 |
Novartis Vaccines And Diagnostics, Inc. |
Estimulacion de anticuerpos especificos de hcv.
|
DK1897555T3
(da)
|
2000-01-17 |
2014-10-13 |
Novartis Vaccines & Diagnostic |
Kompletteret OMV-vaccine mod meningococcus
|
CN1441806A
(zh)
|
2000-04-05 |
2003-09-10 |
先灵公司 |
包含n-环p2部分的丙型肝炎病毒的大环ns3-丝氨酸蛋白酶抑制剂
|
CA2406532A1
(en)
|
2000-04-19 |
2001-11-01 |
Schering Corporation |
Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus compri sing alkyl and aryl alanine p2 moieties
|
US6632601B2
(en)
*
|
2000-06-15 |
2003-10-14 |
Chiron Corporation |
Immunoassays for anti-HCV antibodies
|
EP1829891B1
(en)
*
|
2000-06-15 |
2012-12-26 |
Novartis Vaccines and Diagnostics, Inc. |
Immunoassays for Anti-HCV Antibodies
|
CN1446201A
(zh)
|
2000-07-21 |
2003-10-01 |
先灵公司 |
用作丙型肝炎病毒ns3-丝氨酸蛋白酶抑制剂的新型肽
|
US7012066B2
(en)
|
2000-07-21 |
2006-03-14 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
WO2002014362A2
(en)
*
|
2000-08-17 |
2002-02-21 |
Tripep Ab |
A hepatitis c virus non-structural ns3/4a fusion gene
|
US7022830B2
(en)
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
RU2286172C2
(ru)
|
2000-08-17 |
2006-10-27 |
Трипеп Аб |
Вакцины, содержащие рибавирин, и способы их использования
|
US6680059B2
(en)
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
SG165981A1
(en)
|
2000-10-27 |
2010-11-29 |
Chiron Srl |
Nucleic acids and proteins from streptococcus groups a & b
|
ATE430166T1
(de)
|
2000-12-12 |
2009-05-15 |
Schering Corp |
Diarylrest entfassende peptide als inhibitoren des ns-3 serinproteases von hepatitis c virus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
WO2002099035A2
(en)
|
2001-05-31 |
2002-12-12 |
Chiron Corporation |
Chimeric alphavirus replicon particles
|
US7196183B2
(en)
|
2001-08-31 |
2007-03-27 |
Innogenetics N.V. |
Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
NZ546711A
(en)
|
2001-12-12 |
2008-06-30 |
Chiron Srl |
Immunisation against chlamydia trachomatis
|
EP1467989B1
(en)
|
2002-01-23 |
2009-09-23 |
Schering Corporation |
Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
|
US7501134B2
(en)
|
2002-02-20 |
2009-03-10 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticles with adsorbed polypeptide-containing molecules
|
DK2014671T3
(da)
|
2002-03-11 |
2010-09-20 |
Lab 21 Ltd |
Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C
|
US7598421B2
(en)
|
2002-05-08 |
2009-10-06 |
Ucl Biomedica Plc |
Materials for the delivery of biologically-active material to cells
|
DE60330564D1
(de)
|
2002-05-24 |
2010-01-28 |
Restoragen Inc |
Verfahren und konstrukte zur expression von clostripain mit hoher ausbeute
|
CA2498228C
(en)
|
2002-09-09 |
2011-03-22 |
Chiron Corporation |
Hcv assay
|
US7927840B2
(en)
|
2006-09-11 |
2011-04-19 |
Gen Probe Incorporated |
Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
|
EP2977470B1
(en)
|
2002-10-16 |
2018-01-03 |
Gen-Probe Incorporated |
Compositions and methods for detecting west nile virus
|
EP1585542B1
(en)
|
2002-12-27 |
2012-06-13 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic compositions containing phospholipid
|
JP4839209B2
(ja)
|
2003-02-06 |
2011-12-21 |
アンザ セラピューティクス,インコーポレイテッド |
改変された自由生活微生物、ワクチン組成物、およびそれらの使用方法
|
ATE552843T1
(de)
|
2003-02-06 |
2012-04-15 |
Aduro Biotech |
Listerien deren eindringen in nicht-phagozytische zellen abgeschwächt ist, impfstoffe, die diese listerien enthalten und deren verwendungen
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
US7449447B2
(en)
|
2003-08-26 |
2008-11-11 |
Schering Corporation |
Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
|
US8124747B2
(en)
|
2003-08-29 |
2012-02-28 |
Innogenetics |
HCV clade and prototype sequences thereof
|
JP4342519B2
(ja)
|
2003-09-22 |
2009-10-14 |
株式会社グリーンペプタイド |
C型肝炎ウイルス由来ペプチド
|
DE602004031298D1
(de)
|
2003-09-26 |
2011-03-17 |
Schering Corp |
Makrocyclische inhibitoren der ns3-serinprotease des hepatitis-c-virus
|
RS20110578A3
(en)
*
|
2003-10-14 |
2016-02-29 |
F. Hoffmann-La Roche Ltd |
MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULPHONAMIDES AS HCV REPLICATION INHIBITORS
|
CN1902216A
(zh)
|
2003-11-20 |
2007-01-24 |
先灵公司 |
丙肝病毒ns3蛋白酶的去肽化抑制剂
|
US7842289B2
(en)
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
JP2007525511A
(ja)
|
2004-02-27 |
2007-09-06 |
シェーリング コーポレイション |
C型肝炎ウイルスns3セリンプロテアーゼの新規のインヒビターとしての化合物
|
CA2557247A1
(en)
|
2004-02-27 |
2005-09-22 |
Schering Corporation |
Compounds as inhibitors of hepatitis c virus ns3 serine protease
|
TW200536528A
(en)
|
2004-02-27 |
2005-11-16 |
Schering Corp |
Novel inhibitors of hepatitis C virus NS3 protease
|
DE602005015834D1
(de)
|
2004-02-27 |
2009-09-17 |
Schering Corp |
3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
|
ES2328596T3
(es)
|
2004-05-20 |
2009-11-16 |
Schering Corporation |
Prolinas sustituidas como inhibidores de la serina proteasa del virus ns3 de la hepatitis c.
|
US20090317420A1
(en)
|
2004-07-29 |
2009-12-24 |
Chiron Corporation |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
US7871625B2
(en)
|
2004-08-27 |
2011-01-18 |
Novartis Vaccines And Diagnostics, Inc. |
HCV multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof
|
JP2008511633A
(ja)
|
2004-08-27 |
2008-04-17 |
シェーリング コーポレイション |
C型肝炎ウィルスns3セリンプロテアーゼの阻害因子としてのアシルスルホンアミド化合物
|
US7385028B2
(en)
|
2004-12-22 |
2008-06-10 |
Ambrx, Inc |
Derivatization of non-natural amino acids and polypeptides
|
WO2006116423A2
(en)
|
2005-04-26 |
2006-11-02 |
Eisai Co., Ltd |
Compositions and methods for cancer immunotherapy
|
WO2007031867A2
(en)
|
2005-05-25 |
2007-03-22 |
Tripep Ab |
A hepatitis c virus non-stru tural ns3/4a fusion gene
|
NZ563361A
(en)
|
2005-06-02 |
2011-02-25 |
Schering Corp |
HCV protease inhibitors in combination with food
|
CA2611155A1
(en)
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Pharmaceutical formulations and methods of treatment using the same
|
US9127302B2
(en)
|
2005-09-20 |
2015-09-08 |
Janssen Diagnostics, Llc |
System for the detection and enumeration of suspect target cells in a mixed cell population
|
WO2007135707A1
(ja)
|
2006-05-18 |
2007-11-29 |
Nichia Corporation |
樹脂成形体及び表面実装型発光装置並びにそれらの製造方法
|
EP2054431B1
(en)
|
2006-06-09 |
2011-08-31 |
Novartis AG |
Conformers of bacterial adhesins
|
EP2185195A2
(en)
|
2007-08-16 |
2010-05-19 |
Tripep Ab |
Immunogen platform
|
DK2224954T3
(en)
|
2007-11-07 |
2014-03-03 |
Celldex Therapeutics Inc |
Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
|
EP3067048B1
(en)
|
2007-12-07 |
2018-02-14 |
GlaxoSmithKline Biologicals SA |
Compositions for inducing immune responses
|
CA2712606A1
(en)
|
2008-02-08 |
2009-08-13 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
WO2009130588A2
(en)
|
2008-04-22 |
2009-10-29 |
Tripep Ab |
Immunogen platform
|
US20110287055A1
(en)
|
2008-05-19 |
2011-11-24 |
Aduro Biotech |
Compositions comprising prfa* mutant listeria and mehtods of use thereof
|
CN102232085A
(zh)
|
2008-09-26 |
2011-11-02 |
Ambrx公司 |
修饰的动物促红细胞生成素多肽和其用途
|
US20110286969A1
(en)
|
2008-12-12 |
2011-11-24 |
Schering Corporation |
Deuterated compounds as hepatitis c virus (hcv) inhibitors
|
US20120100171A1
(en)
|
2009-03-09 |
2012-04-26 |
William Henry |
Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions
|
JP2012528195A
(ja)
|
2009-05-29 |
2012-11-12 |
メルク・シャープ・アンド・ドーム・コーポレーション |
C型肝炎などの疾患を処置するための3つの結合アリール部分で構成された抗菌性化合物
|
EP2451475A2
(en)
|
2009-07-06 |
2012-05-16 |
Novartis AG |
Self replicating rna molecules and uses thereof
|
JP2013512246A
(ja)
|
2009-11-25 |
2013-04-11 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ウイルス疾患治療に有用な縮合型三環式化合物およびその誘導体
|
EP2333074A1
(en)
|
2009-12-14 |
2011-06-15 |
Robert Steinfeld |
Substances and methods for the treatment of lysosmal storage diseases
|
JP2013515068A
(ja)
|
2009-12-22 |
2013-05-02 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ウイルス性疾患の治療のための縮合三環式化合物およびその使用方法
|
KR101781789B1
(ko)
|
2010-01-27 |
2017-09-26 |
에이비 파르마 리미티드. |
C형 간염 바이러스 억제제로 사용되는 다환 헤테로사이클릭 화합물
|
BR112012022125A2
(pt)
|
2010-03-09 |
2016-11-01 |
Merck Sharp & Dhme Corp |
composto, sal de dicloridrato, composição farmacêutica, uso do composto, e, método para tratar um paciente
|
WO2011130434A2
(en)
|
2010-04-13 |
2011-10-20 |
Celldex Therapeutics Inc. |
Antibodies that bind human cd27 and uses thereof
|
ES2649896T3
(es)
|
2010-07-06 |
2018-01-16 |
Glaxosmithkline Biologicals Sa |
Emulsiones catiónicas de aceite en agua
|
WO2012018534A2
(en)
|
2010-07-26 |
2012-02-09 |
Schering Corporation |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
JP2013540122A
(ja)
|
2010-09-29 |
2013-10-31 |
メルク・シャープ・エンド・ドーム・コーポレイション |
縮合四環式化合物誘導体およびウィルス疾患治療のためのそれの使用方法
|
WO2012142075A1
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
KR20130138840A
(ko)
|
2011-04-13 |
2013-12-19 |
머크 샤프 앤드 돔 코포레이션 |
2''-치환된 뉴클레오시드 유도체 및 바이러스성 질환의 치료를 위한 그의 사용 방법
|
CA2857705A1
(en)
|
2011-06-16 |
2012-12-20 |
AB Pharma Ltd. |
Macrocyclic heterocyclic compounds for inhibiting hepatitis c virus and preparation and use thereof
|
EP2729125B1
(en)
|
2011-07-06 |
2017-12-13 |
GlaxoSmithKline Biologicals SA |
Oil-in-water emulsions that contain nucleic acids
|
CA2840965C
(en)
|
2011-07-06 |
2021-03-02 |
Novartis Ag |
Cationic oil-in-water emulsions
|
WO2013039876A1
(en)
|
2011-09-14 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
MX2014004214A
(es)
|
2011-10-11 |
2014-05-07 |
Novartis Ag |
Moleculas de acido ribonucleico policistronicas auto-replicantes recombinantes.
|
US20180044429A1
(en)
|
2015-03-09 |
2018-02-15 |
Celldex Therapeutics, Inc. |
Cd27 agonists
|
DK3274478T3
(da)
|
2015-03-27 |
2020-11-23 |
Ortho Clinical Diagnostics K K |
Hcv-ns4a/modificerede ns3-polypeptider og anvendelser deraf
|
US10550379B2
(en)
|
2015-06-29 |
2020-02-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Degron fusion constructs and methods for controlling protein production
|
WO2017184619A2
(en)
|
2016-04-18 |
2017-10-26 |
Celldex Therapeutics, Inc. |
Agonistic antibodies that bind human cd40 and uses thereof
|